News | June 14, 2026
India clears major milestone in cervical cancer fight with validation of first indigenous HPV DNA test
Cervical cancer remains one of the leading causes of cancer deaths among women in India
Cervical cancer remains one of the leading causes of cancer deaths among women in India
Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards
The regulatory decision follows promising results from RIVER-81
Despite the disruption, the company stressed that “our core business operations are not impacted and remain up and running.
MeRT becomes one of the few FDA-cleared neuromodulation therapies for PTSD, using EEG biomarkers and AI to personalize treatment for patients with treatment-resistant symptoms
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
The milestone, announced from Wilmington, Delaware, is powered through additional Renewable Energy Certificates (RECs) and backed by US-sourced renewable generation
Orbis India Country Director recognized by the Lions Council of India for efforts to expand access to quality eye care among underserved communities.
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
The award places the company in the top 5% globally
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
